5AM Partners VI, LLC - 26 Sep 2023 Form 4 Insider Report for Enliven Therapeutics, Inc. (ELVN)

Role
10%+ Owner
Signature
5AM Partners VI, LLC, By /s/ Kush Parmar, Managing Member
Issuer symbol
ELVN
Transactions as of
26 Sep 2023
Net transactions value
-$2,962,500
Form type
4
Filing time
28 Sep 2023, 16:27:26 UTC
Previous filing
28 Aug 2023
Next filing
02 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELVN Common Stock Sale $2,471,835 -164,789 -3.7% $15.00 4,306,179 26 Sep 2023 By 5AM Ventures VI, L.P. F1
transaction ELVN Common Stock Sale $490,665 -32,711 -3.7% $15.00 854,796 26 Sep 2023 By 5AM Opportunities I, L.P. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are directly held by 5AM Ventures VI, L.P. ("Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of Ventures VI. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VI and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VI. Each of Partners VI, Dr. Parmar and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein.
F2 The shares are directly held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are the managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Dr. Parmar and Mr. Schwab disclaims beneficial ownership of such shares, except to the extent of its or his respective pecuniary interest therein.